Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy.

Tan CC, Yu JT, Tan MS, Jiang T, Zhu XC, Tan L.

Neurobiol Aging · 2013-11-28

DOI: 10.1016/j.neurobiolaging.2013.11.019PMID: 24360503

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity.

Bartl J, Müller T, Grünblatt E, Gerlach M, Riederer P.

J Neural Transm (Vienna) · 2013-11-23

DOI: 10.1007/s00702-013-1120-zPMID: 24272680

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.

Herz DM, Siebner HR, Hulme OJ, Florin E, Christensen MS, Timmermann L.

Neuroimage · 2013-11-22

DOI: 10.1016/j.neuroimage.2013.11.023PMID: 24269570

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson's disease experiencing mild wearing-off: a randomised, double-blind trial.

Tolosa E, Hernández B, Linazasoro G, López-Lozano JJ, Mir P, Marey J, Kulisevsky J.

J Neural Transm (Vienna) · 2013-11-20

DOI: 10.1007/s00702-013-1114-xPMID: 24253234

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: lack of evidence. Authors' reply.

Melo A, Monteiro L.

Parkinsonism Relat Disord · 2013-11-18

DOI: 10.1016/j.parkreldis.2013.10.028PMID: 24300049

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

Klyachko NL, Haney MJ, Zhao Y, Manickam DS, Mahajan V, Suresh P, Hingtgen SD, Mosley RL, Gendelman HE, Kabanov AV, Batrakova EV.

Nanomedicine (Lond) · 2013-11-18

DOI: 10.2217/nnm.13.115PMID: 24237263

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus.

Bonaventura J, Rico AJ, Moreno E, Sierra S, Sánchez M, Luquin N, Farré D, Müller CE, Martínez-Pinilla E, Cortés A, Mallol J, Armentero MT, Pinna A, Canela EI, Lluís C, McCormick PJ, Lanciego JL, Casadó V, Franco R.

Neuropharmacology · 2013-11-11

DOI: 10.1016/j.neuropharm.2013.10.036PMID: 24230991

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Excitatory deep repetitive transcranial magnetic stimulation with H-coil as add-on treatment of motor symptoms in Parkinson's disease: an open label, pilot study.

Spagnolo F, Volonté MA, Fichera M, Chieffo R, Houdayer E, Bianco M, Coppi E, Nuara A, Straffi L, Di Maggio G, Ferrari L, Dalla Libera D, Velikova S, Comi G, Zangen A, Leocani L.

Brain Stimul · 2013-10-29

DOI: 10.1016/j.brs.2013.10.007PMID: 24300835

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson's disease patients.

Schumacher-Schuh AF, Altmann V, Rieck M, Tovo-Rodrigues L, Monte TL, Callegari-Jacques SM, Medeiros MS, Rieder CR, Hutz MH.

Pharmacogenomics J · 2013-10-15

DOI: 10.1038/tpj.2013.37PMID: 24126708

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Thalamic stimulation alleviates levodopa-resistant rigidity in a patient with non-Parkinson's disease parkinsonian syndrome.

Yamada K, Hamasaki T, Kuratsu J.

J Clin Neurosci · 2013-10-11

DOI: 10.1016/j.jocn.2013.07.036PMID: 24291482

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.

Rizzo F, Riboldi G, Salani S, Nizzardo M, Simone C, Corti S, Hedlund E.

Cell Mol Life Sci · 2013-10-08

DOI: 10.1007/s00018-013-1480-4PMID: 24100629

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Modulation of corticomotor excitability after maximal or sustainable-rate repetitive finger movement is impaired in Parkinson's disease and is reversed by levodopa.

Teo WP, Rodrigues JP, Mastaglia FL, Thickbroom GW.

Clin Neurophysiol · 2013-10-01

DOI: 10.1016/j.clinph.2013.09.004PMID: 24095151

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

10.361 makale bulundu

Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy.

Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity.

Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.

Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson's disease experiencing mild wearing-off: a randomised, double-blind trial.

Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: lack of evidence. Authors' reply.

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus.

Excitatory deep repetitive transcranial magnetic stimulation with H-coil as add-on treatment of motor symptoms in Parkinson's disease: an open label, pilot study.

Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson's disease patients.

Thalamic stimulation alleviates levodopa-resistant rigidity in a patient with non-Parkinson's disease parkinsonian syndrome.

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.

Modulation of corticomotor excitability after maximal or sustainable-rate repetitive finger movement is impaired in Parkinson's disease and is reversed by levodopa.

Filtreler